Docuvera is an AI-powered Structured Content Authoring (SCA) platform developed specifically for the pharmaceutical and life sciences industries. It replaces traditional, scattered file-based workflows with modular, traceable, and compliant content components. The platform enables regulated content to be created once and reused across teams, document types, and global markets, which helps reduce cycle times, improve consistency, and modernize content operations.
Key benefits include accelerated compliance, increased efficiency (with claims of up to 50% lower operating costs), and faster time-to-market. The solution is built on a structured content framework and is designed to support the full content lifecycle, including Labeling (CCDS, SmPCs, USPIs), CMC (Module 3), Clinical (Protocols, CSRs), Medical Information, Pharmacovigilance & Safety, and Quality & SOPs.
It features collaborative review and approval workflows, robust version control, and a detailed audit trail to ensure GxP and regulatory compliance. Docuvera is a validation-ready SaaS solution hosted on SOC 2-certified infrastructure and is engineered to align with evolving regulatory and interoperability standards like eCTD 4.0, ePI, DADI, and HL7 FHIR. It is designed to complement existing RIM, QMS, and publishing systems through seamless integrations.